Sanofi India Q3 Result Date Updates, Sanofi is in the business of pharmaceuticals. Sanofi is among top pharma companies. Sanofi is a french company headquartered in Paris, France.
Company’s main therapeutic drugs are Diabetes, Cardiology, Thrombosis, Anti-infectives, Central Nervous System, Allergy and Vitamins, Minerals & Supplements.
They improve their diabetes franchise by growing the insulin market and increase their insulin geographacially.
In 2004, Sanofi-Synthélabo merged with Aventis and new name was Sanofi-Aventis, new product launched by it’s new name.
Its pharmaceutical products include Adenocor, Lantus, Aldurazyme, AllStar, Amaryl MP, Amaryl M, Apidra, Arava, Aubagio and Thymoglobuline.
Its specialty care products include Myozyme, Cerezyme, Aldurazyme, Aubagio and Jevtana. Its consumer healthcare products include Allegra, Allegra nasal, Avil, Combiflam, Combiflam Plus and Lactacyd.
Its vaccines products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT.
Sanofi India Q3 Result Date
Sanofi says ” we would like to inform you that the meeting of the Board of Directors of the Company will be held on Thursday, 23rd February 2023, inter-alia to consider and approve the audited accounts for the quarter and year ended 31 st December 2022. “
Sanofi India Q3 Result Date, Will Sanofi Announced Dividends ?
Recommend dividend, if any, for the Financial Year ended 31 st December 2022. Company gave dividend last time in december quarter last year.
Brokerage Call on Sanofi India
ICICI bullish on pharma company for which the brokerage is bullish for gains up to 19.5 percent. The target price for the stock is Rs. 9800, while the last traded price is Rs. 8199.95.
ICICI Direct values Sanofi at Rs. 9800 i.e. 35x P/E on FY23E EPS.
Share Price History and Stock Returns
In 2002 Sanofi India share price stood at 400 rupees and currently stock at 5350 and make life time high at 8500 rupees in 2020.
Currently company not performed very well in last 4-5 quarters. Company post negative revenue on quarter by quarter.
Also Read :- This Multibagger IT Stock Become 10x in Two Years